NGNE short interest
Neurogene Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 4,974,749 |
|---|---|
| Change vs prior report | 1,694,577 (+51.7%) |
| Change over six months | +23.5% |
| Days to cover | 11.73 (sector: 3.78) |
| Average daily volume | 423,989 |
| Rank in Healthcare | #73 of 922 by days to cover |
NGNE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 4,974,749 | +51.7% | 11.73 | 423,989 |
| 2026-09-15 | 3,280,172 | +4.6% | 16.85 | 194,657 |
| 2026-08-31 | 3,135,369 | +3.2% | 13.58 | 230,841 |
| 2026-08-14 | 3,038,441 | +1.1% | 16.81 | 180,803 |
| 2026-07-31 | 3,005,232 | +2.6% | 16.15 | 186,066 |
| 2026-07-15 | 2,928,178 | -12.7% | 7.57 | 386,893 |
| 2026-06-30 | 3,352,320 | -5.5% | 13.48 | 248,662 |
| 2026-06-15 | 3,548,175 | +0.1% | 22.94 | 154,684 |
| 2026-05-29 | 3,545,963 | -1.6% | 27.48 | 129,045 |
| 2026-05-15 | 3,603,655 | -3.1% | 24.65 | 146,197 |
| 2026-04-30 | 3,720,441 | -7.3% | 19.85 | 187,448 |
| 2026-04-15 | 4,011,809 | -0.4% | 28.64 | 140,085 |
| 2026-03-31 | 4,029,257 | +3.7% | 25.19 | 159,977 |
| 2026-03-13 | 3,885,559 | +5.8% | 19.91 | 195,122 |
| 2026-02-27 | 3,673,771 | +1.9% | 15.61 | 235,342 |
| 2026-02-13 | 3,605,074 | +0.4% | 32.65 | 110,413 |
| 2026-01-30 | 3,591,099 | +1.6% | 31.88 | 112,650 |
| 2026-01-15 | 3,536,210 | +1.0% | 20.17 | 175,308 |
| 2025-12-31 | 3,502,155 | -1.0% | 18.12 | 193,307 |
| 2025-12-15 | 3,538,773 | +7.7% | 18.30 | 193,412 |
| 2025-11-28 | 3,285,408 | -0.9% | 15.75 | 208,609 |
| 2025-11-14 | 3,315,140 | +16.6% | 11.00 | 301,508 |
| 2025-10-31 | 2,844,441 | -0.5% | 13.06 | 217,868 |
| 2025-10-15 | 2,858,834 | +0.8% | 9.65 | 296,369 |
| 2025-09-30 | 2,835,224 | +0.4% | 19.02 | 149,099 |
import finzdata as yf
yf.Ticker("NGNE").short_interest # every report since 2017
yf.Client().short_interest(["NGNE"], start="2018-01-01")Healthcare short interest · NGNE price history · Who owns NGNE · All short interest